Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Hepatitis B Vaccine Nonresponders
NCT01548326Phase 4Unknown
- Start
- Sep 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hepatitis B (HBV) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Change from baseline in serum HBsAb level at 1 month. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01548326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01548326.